ConductScience.org, home

Trial · NCT03021902

Nutrition and Exercise in Critical Illness

NCT03021902, Phase 2, Completed, Clinical Evaluation Research Unit at Kingston General Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Nutrition and Exercise in Critical Illness. Trials, record NCT03021902. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03021902

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Nutrition and Exercise in Critical Illness
NCT number
NCT03021902
Status
Completed
Phases
Phase 2
Enrollment
115 participants, actual
Lead sponsor
Clinical Evaluation Research Unit at Kingston General Hospital
Conditions
Acute Respiratory Failure
Interventions
IV amino acids, In-bed cycle ergometry exercise
First posted
2017-01-16
Last updated
2025-08-27

Source ClinicalTrials.gov

Registered outcomes35

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPhysical functioningHospital discharge (up to 26 weeks after randomization)6-minute walk distance
SecondaryOverall strength-upper extremityHospital discharge (up to 26 weeks after randomization)MRC Sum-score (Medical Research Council (MRC) Scale for Muscle Strength). Subscales scored 0-5, where 5 is normal. Total score is the sum of the 6 upper extremity subscales.
SecondaryOverall strength-lower extremityHospital discharge (up to 26 weeks after randomization)MRC Sum-score (Medical Research Council (MRC) Scale for Muscle Strength). Subscales scored 0-5, where 5 is normal. Total score is the sum of the 6 lower extremity subscales.
SecondaryQuadriceps force-lower extremity strengthHospital discharge (up to 26 weeks after randomization)Hand held dynamometry
SecondaryDistal strength-hand grip strengthICU and hospital discharge (up to 26 weeks after randomization)Hand held dynamometry
SecondaryOverall Physical Functional status - Short Physical Performance BatteryICU and hospital discharge (up to 26 weeks after randomization)Short Physical Performance Battery
SecondaryOverall Physical Functional status - Functional Status Score - ICUICU and hospital discharge (up to 26 weeks after randomization)
Functional Status Score - ICU 5 items are performed: rolling, transfer from supine to sit, sitting at the edge of bed, transfer from sit to stand, and walking Each task is evaluated using an eight-point ordinal scale ranging from 0 (unable to perform) to 7 (complete independence) Item scores are summed The total score ranges from 0-35, with higher scores indicating better physical functioning.
SecondaryMortalityICU and hospital discharge (up to 26 weeks after randomization)Chart review
SecondaryLength of ventilationICU and hospital discharge (up to 26 weeks after randomization)Chart review
SecondaryICU stayICU and hospital discharge (up to 26 weeks after randomization)Chart review

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers12

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
18766087BACKGROUNDPubMed
19623052BACKGROUNDPubMed
19638746BACKGROUNDPubMed
22307571BACKGROUNDPubMed
22983782BACKGROUNDPubMed
23594003BACKGROUNDPubMed
24835849BACKGROUNDPubMed
25307979BACKGROUNDPubMed
25742048BACKGROUNDPubMed
31371287DERIVEDPubMed

1 to 10 of 12

See all 12 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03021902

GET https://conductscience.org/api/trials/v1/NCT03021902/registered?page=2